Focus: Reflow Medical is an early-stage medical device company focused on catheter-based interventions for cardiovascular and peripheral vascular diseases. Founded in 2024 with ~50 employees, it operates as a public company from San Clemente, CA.
Profile data last refreshed 6h ago · AI intelligence enriched 12h ago
Cooling — net -5 jobs in 30d
0 added, 5 removed. Slower than typical.
Reflow is a high-risk, high-upside early-stage device play suited for entrepreneurial professionals comfortable with ambiguity and equity-based compensation, but unsuitable for those seeking financial stability or established career frameworks.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Reflow Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Reflow Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Cordis Introduces New PTA Drug-Eluting Balloon in Japan - Medical Product Outsourcing
Cordis Introduces New PTA Drug-Eluting Balloon in Japan Medical Product Outsourcing
Abbott’s Longer Length Esprit BTK Drug-Eluting Scaffold Gets FDA OK - Medical Product Outsourcing
Abbott’s Longer Length Esprit BTK Drug-Eluting Scaffold Gets FDA OK Medical Product Outsourcing
Reflow Medical Introduces Next-Gen Torqueable Microcatheters in U.S. - Medical Product Outsourcing
Reflow Medical Introduces Next-Gen Torqueable Microcatheters in U.S. Medical Product Outsourcing
First patient enrolled in study of Reflow Medical’s Spur system - Medical Device Network
First patient enrolled in study of Reflow Medical’s Spur system Medical Device Network
Reflow Medical enrolls first patient in retrievable scaffold trial - MassDevice
Reflow Medical enrolls first patient in retrievable scaffold trial MassDevice
Medical University of Graz Enrolls First Patient in DEEPER CHALLENGE Trial Evaluating Spur - Business Wire
Medical University of Graz Enrolls First Patient in DEEPER CHALLENGE Trial Evaluating Spur Business Wire
Showing 6 of 10 news items
Based on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Early Tibial Vessel Recoil Following Treatment With the Bare Temporary Spur Stent System: Results From the DEEPER OUS Vessel Recoil Substudy.
Preclinical Evaluation of the Temporary Drug-Coated Spur Stent System in Porcine Peripheral Arteries.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo